Related Experiment Video
Updated: Mar 29, 2026

06:11
Author Spotlight: Automating iPSC Culture for Enhanced Reproducibility
Published on: January 26, 2024
2.2K
A high-content platform to characterise human induced pluripotent stem cell lines
Andreas Leha1, Nathalie Moens2, Ruta Meleckyte2
1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
Methods (San Diego, Calif.)
|November 27, 2015
Summary
We developed a high-content platform to analyze human induced pluripotent stem cells (iPSCs). This tool quantifies phenotypic diversity, aiding disease modeling and drug discovery for iPSC therapies.
Area of Science:
- Stem Cell Biology
- Genomics
- Biotechnology
Background:
- Induced pluripotent stem cells (iPSCs) are crucial for cell therapies, disease modeling, and drug discovery.
- Comprehensive characterization of iPSCs from diverse individuals is essential to unlock their full potential.
- The Human iPSC initiative (HipSci) aims to define iPSC phenotypes and understand variability.
Purpose of the Study:
- Establish a high-content platform for detailed phenotypic analysis of human iPSC lines.
- Quantify cell number, proliferation, morphology, and intercellular adhesion.
- Facilitate the identification of factors contributing to variance in iPSC populations.
Main Methods:
- Developed a high-content assay for phenotypic analysis of human iPSC lines.
- Cells were dissociated and seeded as single cells onto 96-well plates.
- Plates were coated with fibronectin at three different concentrations to assess cell behavior.
Main Results:
- The platform enables robust quantification of phenotypic diversity within iPSC populations.
- The assay effectively measures cell number, proliferation, morphology, and intercellular adhesion.
- This strategy provides a foundation for identifying determinants of variance in iPSCs.
Conclusions:
- The established platform offers a robust method for characterizing human iPSC lines.
- This approach supports the benchmarking of iPSCs from multiple donors.
- The platform can be tailored for advanced disease modeling and drug discovery applications.
Related Concept Videos
Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells
4.1K
4.1K
Induced Pluripotent Stem Cells
6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.2K

